Mounjaro (tirzepatide) weight loss

A once-weekly injectable that targets two natural appetite hormones to help regulate hunger and blood sugar — supporting significant, sustainable weight loss. Our pharmacist-led consultation confirms whether Mounjaro is the right fit for you.

James Smith
Mounjaro is one of the most effective weight management medications we prescribe. Patients tell us the once-a-week routine is easy to stick with — and when it's the right match, the results speak for themselves.

James Smith

Head of pharmacy at Jade

/uploads/images/info_card_icons/1776864317syringe.png

Mounjaro (tirzepatide) is a once-weekly injection that targets two appetite-regulating hormones — GLP-1 and GIP.

/uploads/images/info_card_icons/1776864317weight.png

In clinical trials, patients on Mounjaro achieved an average weight loss of over 20% of their starting weight.

/uploads/images/info_card_icons/1776864317calendar-alt.png

Our pharmacists help you manage side effects and guide you through each dose step-up safely.

Frequently asked questions

The most common questions we hear about Mounjaro and our weight management service. For anything more specific, we're happy to help.

Contact us
How does Mounjaro work?

Mounjaro (tirzepatide) targets two appetite-regulating hormones — GLP-1 and GIP — to reduce hunger and improve blood sugar control. This dual action supports significant weight loss alongside lifestyle changes.

How much weight loss can I expect on Mounjaro?

Clinical trials showed an average weight loss of over 20% of starting body weight at the highest dose over 72 weeks. Results depend on the dose, your adherence and lifestyle changes.

What are the side effects of Mounjaro?

The most common side effects are nausea, diarrhoea, reduced appetite, constipation and vomiting — usually mild and tending to settle over the first few weeks or after each dose increase.

How often do I inject Mounjaro?

Once a week, on the same day each week. You inject yourself using a pre-filled pen into the abdomen, thigh or upper arm. Our pharmacist will demonstrate the technique.

Who isn't suitable for Mounjaro?

Mounjaro isn't suitable for anyone with a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia type 2 (MEN2), or who is pregnant or breastfeeding. Our pharmacist will confirm suitability during your consultation.

Start your journey to better health

Don’t wait to get treated. find treatments online or find us in branch